Natera Inc (NTRA)
93.49
+0.61
(+0.66%)
USD |
NASDAQ |
May 01, 11:02
Natera Enterprise Value: 10.84B for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 10.84B |
| April 29, 2024 | 10.98B |
| April 26, 2024 | 10.69B |
| April 25, 2024 | 10.64B |
| April 24, 2024 | 10.67B |
| April 23, 2024 | 10.61B |
| April 22, 2024 | 10.32B |
| April 19, 2024 | 9.909B |
| April 18, 2024 | 10.15B |
| April 17, 2024 | 10.53B |
| April 16, 2024 | 10.53B |
| April 15, 2024 | 10.54B |
| April 12, 2024 | 11.03B |
| April 11, 2024 | 11.31B |
| April 10, 2024 | 11.28B |
| April 09, 2024 | 11.40B |
| April 08, 2024 | 11.15B |
| April 05, 2024 | 11.31B |
| April 04, 2024 | 10.77B |
| April 03, 2024 | 10.81B |
| April 02, 2024 | 10.72B |
| April 01, 2024 | 10.85B |
| March 28, 2024 | 10.66B |
| March 27, 2024 | 10.54B |
| March 26, 2024 | 10.49B |
| Date | Value |
|---|---|
| March 25, 2024 | 10.66B |
| March 22, 2024 | 10.77B |
| March 21, 2024 | 10.71B |
| March 20, 2024 | 10.84B |
| March 19, 2024 | 10.64B |
| March 18, 2024 | 10.50B |
| March 15, 2024 | 10.43B |
| March 14, 2024 | 10.08B |
| March 13, 2024 | 10.23B |
| March 12, 2024 | 10.45B |
| March 11, 2024 | 10.27B |
| March 08, 2024 | 10.24B |
| March 07, 2024 | 10.55B |
| March 06, 2024 | 10.38B |
| March 05, 2024 | 10.07B |
| March 04, 2024 | 10.38B |
| March 01, 2024 | 10.28B |
| February 29, 2024 | 9.929B |
| February 28, 2024 | 8.728B |
| February 27, 2024 | 8.681B |
| February 26, 2024 | 8.443B |
| February 23, 2024 | 7.993B |
| February 22, 2024 | 7.993B |
| February 21, 2024 | 7.826B |
| February 20, 2024 | 7.904B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.034B
Minimum
Mar 18 2020
11.60B
Maximum
Sep 17 2021
5.437B
Average
4.939B
Median
Aug 21 2020
Enterprise Value Benchmarks
| Exact Sciences Corp | 12.36B |
| Mettler-Toledo International Inc | 28.42B |
| Danaher Corp | 193.81B |
| Illumina Inc | 19.98B |
| Castle Biosciences Inc | 338.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -78.03M |
| Revenue (Quarterly) | 311.10M |
| Total Expenses (Quarterly) | 395.64M |
| EPS Diluted (Quarterly) | -0.64 |
| Gross Profit Margin (Quarterly) | 51.38% |
| Profit Margin (Quarterly) | -25.08% |
| Earnings Yield | -4.05% |
| Normalized Earnings Yield | -4.054 |